Skip to search boxSkip to navigationSkip to main content

Autophagy is activated to protect against endotoxic acute kidney injury

*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Endotoxemia in sepsis, characterized by systemic inflammation, is a major cause of acute kidney injury (AKI) in hospitalized patients, especially in intensive care unit; however the underlying pathogenesis is poorly understood. Autophagy is a conserved, cellular catabolic pathway that plays crucial roles in cellular homeostasis including the maintenance of cellular function and viability. The regulation and role of autophagy in septic or endotoxic AKI remains unclear. Here we show that autophagy was induced in kidney tubular cells in mice by the endotoxin lipopolysaccharide (LPS). Pharmacological inhibition of autophagy with chloroquine enhanced LPS-induced AKI. Moreover, specific ablation of autophagy gene 7 (Atg7) from kidney proximal tubules worsened LPS-induced AKI. Together, the results demonstrate convincing evidence of autophagy activation in endotoxic kidney injury and support a renoprotective role of autophagy in kidney tubules.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Article number

22171

Journal (Volume, Issue Number)

Scientific reports (Volume 6)

Publication milestones

  • Published - 02/26/2016

Publication status

Published - 02/26/2016

ISSN

2045-2322

Publication IDs

  • Scopus: 84959272976
  • PubMed: 26916346

Publication metrics

Metrics

SciVal
FWCI
1.94
SciVal
Author count
6
SciVal
citations
50
SciVal
Paper percentile
96
SciVal
Top percentile
5
Scopus
citations
Fractional count
2
Fractional count
0.33
Fractional count
4
Fractional count
0.67
Fractional count
2
Fractional count
1

PlumX, opens in new tab

Captures
44
Citation count
98

Funding Details

We thank Dr. Joseph A. Hill at University of Texas Southwestern Medical Center (Dallas, TX), Dr. Masaaki Komatsu at Tokyo Metropolitan Institute of Medical Science (Tokyo, Japan), and Dr. Volker Haase at Vanderbilt University School of Medicine (Nashville, TE) for generously providing CAG-RFP-EGFP-LC3, Atg7flox/flox, and PEPCK-Cre transgenic mice, respectively. This study was supported by grants from National Natural Science Foundation of China (81430017), Major Fundamental Research Program of Shanghai Committee of Science and Technology (12DJ1400300), Shanghai Top Priority Key Clinical Disciplines Construction Project, the National Institutes of Health and Department of Veterans Administration of USA.